Get started
Author

J. Daoud

148eP Molecular subtype–stratified 3-year overall survival in Breast Cancer: Real-world Kaplan–Meier evidence from Sfax, Tunisia
2026 · D. Louay, A.F. Cherif, et al. · ESMO Open
PDF
721eP Late presentation and high prevalence of luminal B and HER2-overexpressing breast cancer in Sfax, Tunisia: Real-world data (2020–2023)
2026 · D. Louay, A.F. Cherif, et al. · ESMO Open
47eP Clinicopathologic characteristics of HER2-low localized breast cancer in Tunisia: A comparative study of HER2 1+ and HER2 2+/FISH-negative subgroups
2025 · W. Ben Kridis, C. Belfekih Hassen, et al. · Annals of Oncology
Pb2092: Primary Bone Diffuse Large B Cell Lymphoma: a Single Center Experience
2022 · G. Abichou, M. Charfi, et al. · HemaSphere
Pb2094: Primary Mediastinal B-cell Lymphoma: Experience of the Hematology Department of Sfax
2022 · M. Charfi, G. Abichou, et al. · HemaSphere
Les chordomes cervicaux mimant une tumeur oropharyngée
2022 · F. Elloumi, L. Ghorbal, et al. · Pratique Neurologique - FMC
PO-1562 Should we delineate brachial plexus in case of breast cancer hypofractionated radiotherapy?
2022 · F. Dhouib, M. Frikha, et al. · Radiotherapy and Oncology
PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
2022 · F. Dhouib, N. Fourati, et al. · Radiotherapy and Oncology
PDF
PO-1139 Hypofractionated radiotherapy for glioblastoma: therapeutic outcomes, toxicities and quality of life
2022 · F. Dhouib, S. Zouari, et al. · Radiotherapy and Oncology
PO-1087 Tumour volume response to induction chemotherapy in nasopharyngeal carcinoma: TPF versus GP
2022 · O. Nouri, W. Mnejja, et al. · Radiotherapy and Oncology
PO-1563 What are the oesophagus dosimetric constraints during breast cancer hypofractionated radiotherapy?
2022 · F. Dhouib, M. Frikha, et al. · Radiotherapy and Oncology
Quelle place pour la chimioradiothérapie postopératoire dans la prise en charge thérapeutique des adénocarcinomes de l’estomac et de la jonction œsogastrique ?
2016 · H. Ben Salah, M. Bahri, et al. · Cancer/Radiothérapie
PO-078: Concurrent Cisplatin-radiotherapy with or without induction chemotherapy in nasopharyngeal carcinoma
2015 · W. Mnejja, N. Toumi, et al. · Radiotherapy and Oncology
Works count: 14
Citation count:
H-index:
I10-index:
Year
Topic
Type